openPR Logo
Press release

Radiopharmaceuticals Market Size, Share, Report and Forecast 2024-2032

11-30-2023 07:54 AM CET | Health & Medicine

Press release from: Expert Market Research

Radiopharmaceuticals Market Size, Share, Report and Forecast

The global radiopharmaceuticals market size was valued at USD 5.3 billion in 2023, driven by the increasing prevalence of chronic diseases across the globe. The market size is anticipated to grow at a CAGR of 7.5% during the forecast period of 2024-2032 to achieve a value of USD 10.2 billion by 2032.

Request a free sample copy in PDF or view the report summary: https://www.expertmarketresearch.com/reports/radiopharmaceuticals-market/requestsample

Radiopharmaceuticals: Introduction

Radiopharmaceuticals are medicinal compounds containing radioactive isotopes used in nuclear medicine for diagnostic or therapeutic purposes. In diagnostic applications, these compounds emit gamma rays, aiding in imaging processes like positron emission tomography (PET) or single-photon emission computed tomography (SPECT). Radiopharmaceuticals are crucial for visualizing and understanding physiological processes in the body. In therapeutic applications, they deliver targeted radiation to specific tissues, treating conditions such as cancer. The radioactive isotopes used typically have short half-lives, allowing for controlled exposure and minimizing radiation risk to patients. Radiopharmaceuticals play a vital role in personalized medicine and disease management.

Key Trends in the Global Radiopharmaceuticals Market

In the current landscape of the global radiopharmaceuticals market, several key trends are shaping the industry. The adoption of theranostics, an innovative approach combining diagnostic and therapeutic capabilities in a single agent, is on the rise. This trend is facilitating personalized treatment strategies, particularly in the field of cancer care.

Utilization of Positron Emission Tomography-Computed Tomography (PET-CT) imaging is witnessing an upswing, driven by its accuracy in providing both anatomical and functional insights. The applications of radiopharmaceuticals in oncology continue to expand, with a focus on developing new agents for diverse cancer types.

Technological advancements play a pivotal role, enhancing the efficacy and safety of radiopharmaceuticals. Ongoing innovations encompass the development of new radioisotopes, improved production processes, and novel delivery systems. The global increase in cancer incidence remains a primary driver for the market, necessitating effective diagnostic tools and therapeutic interventions.

There is a notable interest in alpha and beta emitters for targeted radionuclide therapy, offering advantages in delivering high radiation doses to cancer cells while minimizing damage to healthy tissues. Strategic collaborations and partnerships among industry players are prevalent, aiming to bolster product portfolios, access new technologies, and expand global market presence.

Regulatory developments continue to shape the market, with companies ensuring compliance with evolving standards and seeking approvals for novel radiopharmaceuticals. The globalization of market presence is evident as companies explore opportunities in emerging markets and form alliances to meet the growing demand for nuclear medicine solutions.

Explore the full report with the table of contents@ https://www.expertmarketresearch.com/reports/radiopharmaceuticals-market

Global Radiopharmaceuticals Market Segmentation

Global Radiopharmaceuticals Market Segmentation

Market Breakup by Product Type

Diagnostic Nuclear Medicine
SPECT Radiopharmaceuticals
Technetium-99m
Thallium-201
Gallium-67
Iodine-123
Other

PET Radiopharmaceuticals
F-18
RU-82
Others

Therapeutic Nuclear Medicine
Alpha Emitters
Ra-223
Brachytherapy Isotopes
Intoiodine-125
Palladium-103
Cesium-131
Iridium-192
Other brachytherapy isotopes

Beta Emitters
Intoiodine-131
Yttrium-90
Samarium-153
Lutetium-177
Rhenium-186
Other beta emitters

Market Breakup by Applications

Diagnostic Applications
SPECT Applications
Cardiology
Bone Scans
Thyroid Applications
Pulmonary Scans
Other SPECT Applications

PET applications
Oncology
Cardiology
Neurology
Other PET applications

Therapeutic Applications
Thyroid Indications
Bone Metastasis
Lymphoma
Endocrine Tumors
Other Indications

Market Breakup by Volume Assessment

Diagnostic Procedures
Therapeutic Procedures

Market Breakup by Source

Nuclear Rectors
Cyclotrons

Market Breakup by End User

Hospitals
Ambulatory Surgical Centres
Diagnostic Centres
Cancer Research Institutes
Others

Market Breakup by Region

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Global Radiopharmaceuticals Market Overview

As of the latest assessments, the global radiopharmaceuticals market exhibits distinctive trends across various geographical regions. In North America, particularly the United States, the market holds a substantial share, propelled by a well-established healthcare infrastructure and a rising incidence of cancer. Europe, encompassing key nations like Germany, France, and the United Kingdom, stands as a significant player, benefitting from advanced medical research capabilities and an increasing focus on personalized medicine.

In the Asia-Pacific region, including China, India, and Japan, there is a notable surge in demand for radiopharmaceuticals. Factors such as a growing prevalence of chronic diseases, improving healthcare infrastructure, and heightened awareness of nuclear medicine's diagnostic and therapeutic benefits contribute to this expansion. Latin American countries, led by Brazil and Mexico, are gradually adopting nuclear medicine technologies, contributing to the region's market growth.

The Middle East and Africa are witnessing steady growth in the radiopharmaceuticals market, with countries like Saudi Arabia and South Africa playing pivotal roles. The increasing incidence of cancer and other chronic diseases is driving demand for diagnostic tools and therapeutic interventions, including radiopharmaceuticals.

Global Radiopharmaceuticals Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

Cardinal Health
GE Healthcare
Lantheus Medical Imaging
Bayer AG
Nordion
NTP Radioisotopes
NorthStar Medical Radioisotopes
Eckert & Ziegler
Braun Melsungen AG
Smith Nephew
Zimmer Biomet
Hanger Inc.
Otto Bock Healthcare

About Us:

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analyses provide the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation's future success by acquiring one of our Expert Market Research reports today.

Media Contact:

Company Name: Claight Corporation
Contact Person: Joe Goldberg, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA

Media Contact:

Company Name: Claight Corporation
Contact Person: Joe Goldberg, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA

About Us:

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analyses provide the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organisation's future success by acquiring one of our Expert Market Research reports today.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Radiopharmaceuticals Market Size, Share, Report and Forecast 2024-2032 here

News-ID: 3309869 • Views:

More Releases from Expert Market Research

AI in Mental Health Market to Reach USD 8.38B by 2035
AI in Mental Health Market to Reach USD 8.38B by 2035
How Is Artificial Intelligence Transforming Mental Healthcare? The Artificial Intelligence in Mental Health Market is rapidly emerging as a transformative force in global healthcare, addressing long-standing challenges such as access, affordability, stigma, and workforce shortages. With more than 970 million people worldwide affected by mental health conditions, the need for scalable, personalized, and data-driven mental health solutions has never been more urgent. The global artificial intelligence in mental health market was valued
Brazil Clinical Microbiology Market USD 390.12M | 5.8% CAGR
Brazil Clinical Microbiology Market USD 390.12M | 5.8% CAGR
Why is the Brazil Clinical Microbiology Market gaining strategic importance within Latin America's healthcare ecosystem? Brazil has one of the largest and most complex healthcare systems in the region, with a growing focus on early disease detection, antimicrobial resistance monitoring, and laboratory automation. Clinical microbiology plays a critical role in identifying infectious diseases, guiding targeted therapies, and supporting public health surveillance. The Brazil clinical microbiology market was valued at USD 390.12 Million
Battery Recycling Market Size, Trends and Forecast 2026-2035
Battery Recycling Market Size, Trends and Forecast 2026-2035
The battery recycling market is gaining steady traction as industries and governments focus more on resource efficiency, environmental compliance, and supply chain security for critical metals. With the rising use of lithium-ion, lead-acid, and nickel-based batteries across electric vehicles, consumer electronics, industrial equipment, and energy storage systems, recycling has moved from being a regulatory requirement to a strategic necessity. Battery recycling helps recover valuable materials like lithium, cobalt, nickel, and
Biometrics Technology Market Size, Trends & Forecast 2026-2035
Biometrics Technology Market Size, Trends & Forecast 2026-2035
The biometrics technology market is witnessing robust growth and is expected to continue expanding at a significant pace. Valued at approximately USD 27.78 billion in 2025, the market is projected to grow at a compound annual growth rate (CAGR) of 10.20% between 2026 and 2035. By 2035, the market is expected to reach USD 73.38 billion. This growth is driven by the increasing need for advanced security solutions, innovations in

All 5 Releases


More Releases for Radiopharmaceuticals

Radiopharmaceuticals Market Size, Share | Forecast - 2033
The new report published by The Business Research Company, titled Radiopharmaceuticals Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the radiopharmaceuticals market size has grown steadily in recent years. It will grow from $6.46 billion in 2023 to
Radiopharmaceuticals Market - Harnessing the Power of Radiopharmaceuticals for P …
Newark, New Castle, USA: The "Radiopharmaceuticals Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Radiopharmaceuticals Market: https://www.growthplusreports.com/report/radiopharmaceuticals-market/7842 This latest report researches the industry structure, sales, revenue, price and
Nuclear Medicine/Radiopharmaceuticals Market Growing by Convenience of Radiophar …
Nuclear Medicine/Radiopharmaceuticals Market Outlook 2022-2029 The Nuclear Medicine/Radiopharmaceuticals Market research offers complete knowledge and information on the market's flowing landscape, what is now available on the market, upcoming trends, market expectations, the competitive environment, and methods that may be used to outperform competitors. Market Analysis and Size The Nuclear Medicine/Radiopharmaceuticals Market is currently valued at US$ 10.16 Billion and is projected to register 9.90% CAGR through 2029. Gets a Sample Copy of the Nuclear
Global Radiopharmaceuticals Market Global Radiopharmaceuticals Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Global Radiopharmaceutical Market Overview 1.1 Current Market Scenario 1.2 Diagnostic & Therapeutic Radiopharmaceuticals 1.3 Global Radiopharmaceticals Clinical Pipeline Overview 2. Global Radiopharmaceuticals Market Dynamics 3. Radioisotopes Used in Radiopharmaceuticals 4. EMA Guidelines for Radiopharmaceuticals 4.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products 4.2 Toxicological & Pharmacological Tests 4.3 Clinical Documentation 4.4 Radiation
Nuclear Medicine/Radiopharmaceuticals Market
Radiopharmaceuticals are unique medicinal formulations that contain radioisotopes and are used in clinical applications for diagnosis and therapy. The facilities and procedures for production, use, and storage of radiopharmaceuticals are subject to license approval either by national or regional authorities such as Nuclear Regulatory Commission (NRC) of U.S, Atomic Energy Commission (AEC) of U.S., or Atomic Energy Regulatory Board (AERB) of India. Licensing includes compliance regarding pharmaceutical preparations and use
Global Radiopharmaceuticals Market Insight
Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus. Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a